← Back to Search

Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial (TNT Trial)

N/A

Waitlist Available

Led By Gina Dimitropoulos, PhD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 to 24 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether having a patient navigator helps young people with chronic health conditions move smoothly from child to adult healthcare. The navigator guides them through the new system, making sure they keep their appointments and follow their treatment plans. The goal is to see if this support improves their health and experience during this transition.

Eligible Conditions

Autism Spectrum Disorder
Fetal Alcohol Syndrome
Not a Treatment Study
Kidney Disease
Epilepsy
Endocrine Disorder
Gastrointestinal Disorder
Genetic Diseases
Hematological Disorders
Fetal Alcohol Spectrum Disorders
Autism
Metabolic Diseases
Cardiovascular Disease
Respiratory Diseases
Neurodegenerative Disease
Autoimmune Diseases
Genetic Disorders
Diabetes
Endocrine Disorders
Blood Diseases
Traumatic Brain Injury
Stroke

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 to 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 to 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Health services utilization

Secondary study objectives

Variation in SF-12 Scores

Variation in TRAQ (Transition Readiness Questionnaire) scores

cost analysis

Other study objectives

Youth/Caregiver Satisfaction

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual Care ArmExperimental Treatment1 Intervention

Youth will receive usual care from their pediatric clinics in preparation and transfer to adult care. Participants will receive 5 issues of a provincial generic newsletter on topics around transition. Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months. Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months. Participants will be provided the opportunity to journal online about their experiences.

Group II: Patient Navigator ArmExperimental Treatment1 Intervention

Patient Navigator (Social Worker) will assist youth adapt and attach to adult delivered healthcare for up to 24 months. Participants will receive 5 issues of a provincial generic newsletter on topics around transition. Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months. Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months. Participants will be provided the opportunity to journal online about their experiences. Up to 100 participants will be provided the opportunity to be interviewed at baseline and end of study about their transition experience.

Do I qualify?Apply below to find out